Modified CEA nucleic acid and expression vectors
US7786278B2 · kind B2 · utility
16Cited by
89References
44Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 9, 2003 |
| Grant date | Aug 31, 2010 |
| Priority date | — |
| Expiry date | Aug 15, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/021
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. The invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer. One such foreign DNA sequence is modified CEA nucleic acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.